Worldwide Orthopedic Biomaterials Industry to 2030 - Benchmark Performance Against Key Competitors - ResearchAndMarkets.com

DUBLIN--()--The "Orthopedic Biomaterials Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the global orthopedic biomaterials market.

This report focuses on orthopedic biomaterials market which is experiencing strong growth. The report gives a guide to the orthopedic biomaterials market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Major players in the orthopedic biomaterials market are Zimmer Biomet Holdings Inc., Stryker Corporation, Victrex PLC (Invibio Ltd.), Globus Medical Inc., CAM Bioceramics B.V., Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., Evonik Industries AG, and Koninklijke DSM N.V. (DSM Biomedical B.V.).

The global orthopedic biomaterials market is expected to decline from $12.64 billion in 2019 to $11.43 billion in 2020 at a compound annual growth rate (CAGR) of -9.67%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. Several medical care facilities in affected countries have been completely closed or have been only providing minimal treatment for emergency cases. The orthopedic surgeries have been postponed and, in some cases, cancelled due to the COVID-19 lockdown.

North America was the largest region in the global orthopedic biomaterials market in 2019. Asia Pacific is expected to be the fastest-growing region in the forecast period.

3D printing of orthopedic implants is one of the recent developments in the orthopedic biomaterials market. 3D printing technology is used to produce a large range of medical equipment, such as those with complicated structures or characteristics to suit a patient's particular anatomy. 3D printing of orthopedic implants enables the design of more natural anatomical shapes, as well as the design of porous bone replacement scaffolds that can be easily integrated into the design of the implant. This allows natural bone regeneration to generate higher reliability of the implant. 3D printing of orthopedic implants is a trend in the orthopedic biomaterial market that is attracting many players. For instance, Evonik, a Germany-based chemical company has invested in Meditool, a Chinese based 3d printed implant start-up that produces models and implants by using polyether ketone (PEEK) polymer supplied by Evonik.

The orthopedic biomaterials market covered in this report is segmented by material type into ceramics & bioactive glasses; calcium phosphate cement; polymers; metal; composites and by application into orthopedic implants; joint replacement/reconstruction; bio-resorbable tissue fixation; orthobiologics; viscosupplementation.

The rise in the incidence of musculoskeletal disorders is expected to drive the orthopedic biomaterials market. According to the World Health Organization (WHO) report, musculoskeletal conditions are the leading contributor to disability worldwide. About 20-33% of the population suffer from a musculoskeletal disability.

Key Topics Covered:

1. Executive Summary

2. Orthopedic Biomaterials Market Characteristics

3. Orthopedic Biomaterials Market Size and Growth

3.1. Global Orthopedic Biomaterials Historic Market, 2015 - 2019, $ Billion

3.1.1. Drivers of the Market

3.1.2. Restraints on the Market

3.2. Global Orthopedic Biomaterials Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

3.2.1. Drivers of the Market

3.2.2. Restraints on the Market

4. Orthopedic Biomaterials Market Segmentation

4.1. Global Orthopedic Biomaterials Market, Segmentation by Material Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

4.2. Global Orthopedic Biomaterials Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5. Orthopedic Biomaterials Market Regional and Country Analysis

5.1. Global Orthopedic Biomaterials Market, Split by Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5.2. Global Orthopedic Biomaterials Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Companies Mentioned

  • Zimmer Biomet Holdings Inc.
  • Stryker Corporation
  • Victrex PLC (Invibio Ltd.)
  • Globus Medical Inc.
  • CAM Bioceramics B.V.
  • Heraeus Holding GmbH
  • Exactech Inc.
  • Collagen Matrix Inc.
  • Evonik Industries AG
  • Koninklijke DSM N.V. (DSM Biomedical B.V.)
  • DSM Biomedical
  • DePuy Synthes Inc.

For more information about this report visit https://www.researchandmarkets.com/r/1veyx7

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900